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The ability to accurately diagnose malaria infections, particularly in settings where laboratory facilities are
not well developed, is of key importance in the control of this disease. Rapid diagnostic tests (RDTs) offer great
potential to address this need. Reports of significant variation in the field performance of RDTs based on the
detection of Plasmodium falciparum histidine-rich protein 2 (HRP2) (PfHRP2) and of significant sequence
polymorphism in PfHRP2 led us to evaluate the binding of four HRP2-specific monoclonal antibodies (MABs)
to parasite proteins from geographically distinct P. falciparum isolates, define the epitopes recognized by these
MABs, and relate the copy number of the epitopes to MAB reactivity. We observed a significant difference in
the reactivity of the same MAB to different isolates and between different MABs tested with single isolates.
When the target epitopes of three of the MABs were determined and mapped onto the peptide sequences of the
field isolates, significant variability in the frequency of these epitopes was observed. These findings support the
role of sequence variation as an explanation for variations in the performance of HRP2-based RDTs and point
toward possible approaches to improve their diagnostic sensitivities.
The ability to reliably diagnose malaria infections is funda-
mental to both the management of individual patients as well
as public health efforts to control the disease. Clinical diagnosis
is often unreliable, while microscopic diagnosis, though sensi-
tive and specific, is not universally available. Tests to identify
parasite nucleic acids, principally by PCR, are widely available
in research settings and are becoming increasingly used in
diagnostic laboratories in developed countries. However, such
tests are not currently suitable for use in most areas where
malaria is endemic, as they are not amenable for point-of-care
diagnosis and require sophisticated and expensive equipment
and reagents, highly trained staff, and reliable power supplies.
With the current impetus for the global distribution of increas-
ingly expensive antimalarial drug combinations for multidrug-
resistant parasites, the empirical use of antimalarial drugs fol-
lowing clinical diagnosis is a highly undesirable practice.
Therefore, deployment of reliable rapid diagnostic tests
(RDTs) remains a priority.
Since the development of the first RDT for malaria more
than 10 years ago, over 25 products have been commercially
marketed. Most are based on immunochromatographic anti-
gen detection tests using monoclonal antibodies (MAB) raised
against an abundant circulating protein of Plasmodium falcip-
arum, termed histidine-rich protein 2 (HRP2). While these
tests do not detect infection with other malaria species, RDTs
targeting P. falciparum HRP2 (PfHRP2) have been reported to
display high sensitivity and specificity for the diagnosis of P.
falciparum infection. The sensitivities of these tests have been
reported in some studies to be at least as good as that achieved
by microscopic examination of thick blood films (100 para-
sites/l) (3, 8, 20). However, in other studies, the sensitivities
of these tests have been reported to be well below that re-
quired for operational use (6, 7, 9–11, 13, 17, 25, 27, 29).
Variable test performance has been observed when panels of
blood samples have been tested using different tests targeting
PfHRP2 as well as when the same test has been evaluated in
different locations (2–4, 6, 9, 13, 14, 18, 25, 27, 29). Although
there have been reports of these RDTs failing to detect infec-
tions with high-level parasitemia (5, 9, 11, 27, 29), most of the
variation has occurred with a relatively low level of parasitemia
(100 to 500 parasites/l) (3, 4, 10, 12, 17, 19, 22, 23, 26, 27), a
level that nevertheless often results in symptomatic malaria in
nonimmune individuals (7).
Possible device-related factors that may explain the variable
performance of RDTs include poor manufacture, deteriora-
tion of the device, flawed techniques for carrying out the test,
and misinterpretation of the test results. Possible parasite fac-
tors include the level of parasitemia, variability in the target
epitopes of the parasite antigen, or quantity of parasite antigen
produced by the parasite or present in the peripheral blood.
In previous work, we tested the unexplored hypothesis that
polymorphisms in the PfHRP2 protein may explain some of
the variability in RDT performance. We described significant
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genetic diversity in the PfHRP2 genes from a collection of 75
P. falciparum lines/isolates originating from 19 countries (1).
Extensive diversity was observed in PfHRP2 sequences both
within and between countries (1). We also demonstrated that
the variation in the number and combination of repeats within
PfHRP2 affected the sensitivity of two PfHRP2-based com-
mercial RDTs (1). Therefore, there is a need to evaluate the
effect of HRP2 sequence variation on the binding of MABs
that are being used or that have the potential to be used in
RDTs. In the present study, we sought to define the epitopes
recognized by a panel of four MABs raised against PfHRP2
and to relate the number of PfHRP2 epitopes present in spe-
cific strains of P. falciparum to the recognition of parasite
proteins.
MATERIALS AND METHODS
Parasite isolates. The following eight P. falciparum parasite lines originating
from four different countries, all with unique PfHRP2 gene sequences (1), were
used in this study: AN143, TM91-C32B, FCQ41, INDO21, PH4, FCQ64, SJ15,
and FCQ27-D10. (Table 1).
MABs. Two MABs, 3A4 and 4A5, were kindly provided by David Sullivan,
Department of Molecular Microbiology and Immunology, Johns Hopkins School
of Public Health, Baltimore, MD, while MABs 2G12-1C12 and 1E1-A9 were
kindly provided by Diane Taylor, Department of Biology, Georgetown Univer-
sity, Washington, D.C.
Preparation of parasite protein samples. P. falciparum isolates were cultured
in vitro using standard methods (28), synchronized repeatedly using a standard
sorbitol protocol (15), and harvested at ring stages (100% rings in 1,000 eryth-
rocytes). An aliquot of 1  107 parasite-infected erythrocytes was collected from
the culture, and protein extracts were prepared by subjecting cells to three
freeze-thaw cycles, followed by a 30-min incubation on ice in 50 l phosphate-
buffered saline (PBS) containing 1% Triton X-100 and a protease inhibitor
cocktail (Proteinase Inhibitor Mini Cocktail tablets; Roche). Samples were cen-
trifuged at 15,000  g, and the supernatant was collected as a water-soluble
protein extract and stored at 20°C in aliquots until needed.
Dot blot analysis. A total parasite protein extract was prepared in PBS in
doubling dilutions; 15 l of each dilution was transferred onto a nitrocellulose
membrane by vacuum aspiration in a dot blot apparatus. Membranes were
blocked with 2% casein–Tris-buffered saline (TBS) and incubated with the
MABs diluted 1:2,000 in TBS–2% casein. Following washing in TBS-Tween
(TBS, 0.5% Tween 20), the alkaline phosphatase-conjugated goat anti-mouse
immunoglobulin secondary antibody (Sigma) was added in a dilution of 1:5,000
in TBS–2% casein. Incubations with both primary and secondary antibodies were
carried out for 1 h at room temperature. Detection of positive signals was
undertaken by visualizing chemiluminescence with the CDP-STAR substrate
(Amersham Bioscience) and captured on autoradiography film.
Western blot analysis. Parasite proteins were separated by 8% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis under denaturing and reducing con-
ditions using -mercaptoethanol and transferred onto a polyvinylidene difluoride
membrane using the Bio-Rad Mini-PROTEAN 3 cell system. Membranes were
blocked as described above for dot blot experiments and cut into strips of 3- to
4-mm width. Strips were incubated with the MABs at a dilution of 1:4,000 in
TBS–2% casein. This was followed by secondary antibody incubation and detec-
tion as outlined above for the dot blot analysis.
Epitope mapping. The amino acid sequences encoded by the HRP2 genes
were derived from the respective DNA sequences of the 46 different P. falcipa-
rum isolates reported in our previous publication (1). To cover all possible
epitopes, a peptide library encompassing a total of 171 peptides, representing
combinations of all 46 PfHRP2 sequences, each of 15 residues and overlapping
sequentially by three amino acids, was synthesized. (Mimotopes Pty. Ltd., Clay-
ton, Victoria, Australia). The peptides were synthesized with a biotin residue at
the N terminus followed by an SGSG spacer. The peptides were coated onto
streptavidin (5 g/ml)-coated 96-well polycarbonate plates (Nunc Maxisorb).
Plates were washed with TBS-Tween, blocked with PBS–1% casein, and incu-
bated at room temperature for 1 h with 100 l of each MAB (diluted 1:1,000 in
PBS). Plates were then washed with PBS–0.1% Tween and incubated with a
secondary antibody (horseradish peroxidase-conjugated anti-mouse immuno-
globulin; Sigma) diluted 1:2,000 in PBS. Plates were developed using freshly
prepared ABTS [2,2-azinobis(3-ethylbenzthiazolinesulfonic acid)] substrate so-
lution, and the optical density (OD) at 405 nm was measured after 35 min. The
epitope recognized by each MAB was determined by arranging in hierarchical
order the OD values obtained with each peptide such that peptides with the
highest OD were determined to contain the optimal or complete epitope. Those
peptides with a positive signal but a lower OD were judged to contain only partial
or suboptimal epitopes.
Identification of the minimal epitope. Once peptides that were reactive to each
MAB were identified, they were subjected to further mapping by a glycine scan.
Briefly, for each reactive peptide, a set of 10-mer peptides was synthesized, each
of which had one amino acid replaced by a glycine residue. A total of 47 peptides
were synthesized. All peptides carried biotin plus an SGSG spacer at the N
terminus. The reactivity of each of these peptides with each MAB was tested as
outlined above.
Statistical analysis. Linear regression analysis was performed to test the re-
lationship between epitope frequency and dot blot reactivity. Dot blot reactivity
was assumed to be an ordinal variable based on the minimum dilution returning
a positive test. The dilution categories ranged from 1 (1:32 dilution) to 7 (1:2,048
dilution). Potential differences in epitope frequencies in isolates from different
geographic regions were tested using the Kruskal-Wallis test. When a significant
result was obtained (P  0.05), post hoc comparisons were conducted to deter-
mine which regions differed. Statistical analysis was performed using the SPSS
software package (version 13.0; SPSS Inc.).
RESULTS
Dot blot analysis of recognition of parasite antigen by
PfHRP2 MABs reveals significant variability. All four MABs,
3A4, 4A5, 2G12-1C12, and 1E1-A9, reacted with protein ex-
tracts of the eight parasite cultures bound to the nitrocellulose
membrane (Fig. 1). No reactivity was seen in dot blot analysis
with uninfected red blood cells (Fig. 2). A variation in the
strength of reactivity to individual parasite lines was observed
for each MAB tested (Fig. 1). MABs 3A4 and 2G12-1C12
reacted strongly with TM91-C32B; moderately with AN143,
FCQ41, and FCQ64; and weakly with PH4, while MAB
1E1-A9 reacted weakly with all lines tested except PH4. MAB
4A5 reacted weakly with all parasite lines tested.
None of the MABs reacted strongly with FCQ27-D10, a
strain that lacks the HRP2 gene, in accordance with previous
reports (1, 15). However, as some low-level reactivity of each
MAB to FCQ27-D10 was evident in the dot blot (Fig. 1 and 2),
Western blot analysis was performed to investigate possible
cross-reactivity to other P. falciparum proteins.
Western blot analysis of recognition of parasite antigens by
PfHRP2 MABs indicates recognition of PfHRP2 and other
HRPs under denatured and reduced conditions. Western blot
analysis of protein extracts from eight parasite lines indicated
that all four MABs recognize parasite antigens in a denatured
and reduced form. As was observed in the dot blot analysis, no
reactivity was seen with uninfected red blood cells in the West-
ern blot analysis (data not shown). A representative Western
TABLE 1. Isolates of Plasmodium falciparum cultured
during the study and their origins
Strain Location


















blot is shown in Fig. 3, and a summary of data for the recog-
nition of bands of specific molecular weights is shown in Table 2.
The previously reported apparent molecular masses upon
polyacrylamide gel electrophoresis of three histidine-rich pro-
teins, knob-associated HRP1 (KAHRP), HRP2, and HRP3,
were 80 to 115 kDa, 60 to 115 kDa, and 40 to 55 kDa, respec-
tively (24). As had previously been observed (24), multiple
bands were observed by Western blot analysis using HRP-
specific MABs. While the pattern of recognition of each of the
four MABs was distinct, a band or bands were observed at63
kDa for all four MABs except in D10. Bands were also con-
sistently present at 37 kDa, 82 kDa, and 181 kDa (data not
shown). We therefore assigned the identity of the bands at63
kDa as HRP2, while the band at 37 kDa was identified as
HRP3. The identities of the bands at 82 and 181 kDa are
uncertain. The former may represent KAHRP or HRP2, while
the identity of the band at 181 kDa is unknown. Of note,
parasite line PH4 showed a quite distinct reactivity by Western
blot compared with other strains, as represented by multiple
bands at different sizes with all four antibodies (Fig. 3).
Epitope mapping. In initial epitope mapping, three of the
four MABs tested positive, each recognizing different epitopes.
MAB 3A4 recognized DAHHAHHA as its major epitope, with
possible substitutions of Y or V for the first and last amino
acids. The optimal epitope for MAB 1E1-A9 was similar, rec-
ognizing YAHHAHHA as its major epitope and allowing pos-
FIG. 1. Dot blot analysis of protein extracts from eight P. falciparum isolates. Parasite protein extracts were prepared in doubling dilutions of
1/2 to 1/2,048 before application to each membrane as indicated at the bottom of each panel. Membranes were then incubated with the four
monoclonal antibodies 4A5, 3A4, 2G12-1C12, and 1E1-A9.
FIG. 2. Control dot blot analysis of protein extracts from unin-
fected red blood cells (RBC) and two P. falciparum isolates. Protein
extracts were prepared at a dilution of 1/8 before application onto each
membrane, as indicated at the bottom of each row. Membranes were
then incubated at a dilution of 1/2,000 with the four monoclonal an-
tibodies 4A5, 3A4, 2G12-1C12, and 1E1-A9.
FIG. 3. Western blot analysis of protein extracts of two P. falcipa-
rum isolates, TM91-C32B and PH4, using the four monoclonal anti-
bodies 4A5, 3A4, 2G12-1C12, and 1E1-A9. Molecular masses (in kilo-
daltons) are shown at the left side of each panel.










sible substitutions of D or V for its first or last amino acid.
MAB 2G12-1C12 recognized the major epitope DAHHAAD
AHH, with possible substitutions of H and V at the first and
fifth amino acids (see the supplemental material). Attempts to
define the epitope recognized by MAB 4A5 using the peptide
library were unsuccessful.
To further define the composition and the minimum size of
the epitopes recognized by the MABs, a glycine scan of the
predicted epitopes was performed. The results indicated that
the minimal epitope recognized by MAB 3A4 was AHHA
HHA. Substitution of the first or last amino acid significantly
decreased the OD reading (see the supplemental material).
The minimal epitope recognized by MAB 1E1-A9 was AHHA
HHV. Substitution of the first or last amino acid also significantly
decreased the OD reading (see the supplemental material). The
glycine scan of MAB 2G12-1C12 demonstrated no differences
from background readings. It is suspected that the epitope may be
longer than 10 amino acids.
Copy number of epitopes and correlation with dot blot re-
activity in the eight test isolates. The numbers of major
epitopes of 3A4, 1E1, and 2G12 in the HRP2 and HRP3
proteins of the eight isolates tested by dot blot are listed in
Table 3. For each MAB, the frequency of the epitopes in eight
isolates was compared with the dot blot reactivity. For MAB
3A4, a moderate level of correlation between the copy number
of epitopes in the sequence and the minimum dilution of the
dot blot results was observed. A significant regression model
(R2 	 0.522; P 	 0.043) using the epitope frequency to predict
dot blot reactivity was obtained: dilution category 	 2.06 
0.19  number of AHHAHHA repeats in sequence. Hence,
the number of times the epitope AHHAHHA appeared in the
isolate sequence for the HRP2 and HRP3 proteins predicted
the reactivity with MAB 3A4, with the maximum dilution in-
creasing with increasing epitope frequency. For MAB1E1-A9,
however, no significant association between the number of
AHHAHHV epitopes in the sequence and the dot blot results
using either the actual dilution or the dilution category was
observed.
Comparison of epitope frequency between countries. When
the frequencies of MAB 3A4 epitopes in the HRP2 and HRP3
sequences of 71 parasite isolates (1) from eight countries were
classified according to geographic region, two distinct groups
were identified. Group 1 (higher frequency of AHHAHHA)
included Cambodia, Vietnam, Solomon Islands, Thailand, and
Papua New Guinea. The second group (lower frequency of
AHHAHHA) included Africa, South America, Indonesia, and
Malaysia. Isolates from the Philippines had an intermediate
value that differed significantly from those of Cambodia/Viet-
nam (highest frequency) and Indonesia/Malaysia (lowest fre-
quency). However, the copy numbers in this group did not
significantly differ from those of the isolates from the rest of
the countries.
For MAB 1E1, multiple comparisons again indicated that
the parasites segregated into two groups according to geo-
graphic origin. Group 1 (higher frequency of AHHAHHV)
included South America, Thailand, Solomon Islands, Cambo-
dia, and Vietnam. The second group (lower frequency of AH
HAHHV) included the Philippines, Papua New Guinea, Indo-
TABLE 2. Reactivities of MABs against parasite proteins determined by Western blot analysisa
MAB Molecular mass(kDa) (Ag)
Reactivity with parasite strain:
AN143 TM91-C32B FCQ41 INDO21 PH4 FCQ64 SJ15 D10
3A4 63 (HRP2)       
37 (HRP3)     
181  
82
4A5 63 (HRP2)       
37 (HRP3)  
181  
82  
2G12-1C12 63 (HRP2)       
37 (HRP3)   
181  
82   
1E1-A9 63 (HRP2)       
37 (HRP3)  
181  
82 
a  indicates that reactivity was present.









Africa 12 14.0 (11–18) 2.9 (1–6)
Indonesia/Malaysia 3 13.0 (12–15) 1.7 (1–3)
Philippines 20 14.6 (10–17) 2.1 (1–4)
Papua New Guinea 9 15.0 (9–18) 2.0 (1–4)
Cambodia/Vietnam 5 16.4 (15–17) 3.4 (2–6)
Solomon Islands 7 16.0 (14–18) 3.3 (2–6)
South America 8 13.9 (13–15) 3.6 (2–5)
Thailand 7 16.0 (12–21) 3.6 (1–5)










nesia, and Malaysia. For this epitope, Africa had an
intermediate value that differed significantly from those from
South America (highest frequency) and the Philippines, but it
was not significantly different from those from the remaining
countries.
DISCUSSION
We recently reported extensive diversity in PfHRP2 proteins
among parasite isolates from around the world and demon-
strated an association between this diversity and the sensitivity
of two RDTs (1). This led us to explore possible approaches to
improving the current RDTs by using MABs that are not
affected by sequence diversity or by including several MABs
that detect different B-cell epitopes of HRP. In this paper, we
investigated the affinity of binding of four primary antibodies
that could be used in HRP2-based RDTs.
Initial dot blot experiments were aimed at investigating the
sensitivity of the four tested MABs against the eight different
strains of P. falciparum HRP2 in a native and nondenatured
and nonreduced form. The preparations used were thus para-
sitized erythrocyte protein preparations, preparations that
mimic the physicochemical environment present in rapid diag-
nostic tests on the market. Therefore, the results could be an
indication of the potential sensitivity of these antibodies when
utilized in RDTs.
The results showed a variation between the four antibodies
against each strain. The sensitivity of detection of some strains
was significantly higher than those of other strains. For MABs
3A4 and 2G12, both antibodies were able to detect TM91-
C32B at a very high intensity at a dilution of more than 1:1,024,
while strain PH4 was detectable only to a dilution of 1:32.
Opposite results were observed with antibody 1E1-A9. The
antibody was able to detect strain PH4 with high sensitivity,
while other strains were detected less strongly. This indicates
that the low reactivity of MABs 3A4 and 2G12 with PH4 was
not due to the degradation of proteins in some isolates and
that the genetic variation of P. falciparum strains likely has a
major effect on the binding affinity of the antibodies. The dot
blot results demonstrate that if an RDT for malaria used one
of these three antibodies, the RDT would likely be less readily
able to detect infections with some strains at moderate or
lower levels of parasitemia. Theoretically, a combination of
3A4 and 1E1-A9 or 2G12-1C12 and 1E1-A9 would facilitate
the detection of all eight isolates at similar parasite levels.
The negative control clone of D10 displayed weak reactivity
with all four antibodies in dot blot analyses, suggesting possible
cross-reactivity with other parasite proteins. This cross-reactiv-
ity was confirmed by Western blot analysis, as all four MABs
recognized both HRP2, a single band or multiple bands be-
tween the 63-kDa and 82-kDa markers, and additional bands
around 37.1, 82, and 181 kDa. It is known that P. falciparum-
infected erythrocytes synthesize at least three HRPs: KAHRP,
which has an apparent molecular mass of 80 to 115 kDa by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis;
HRP2, which has a molecular mass ranging from 60 to 105
kDa; and HRP3 (SHARP), with a molecular mass of 40 to 55
kDa (16, 24). Monoclonal antibodies generated against one
HRP have been shown to cross-react with other HRPs (21, 24).
Therefore, it is likely that HRP3 and HRP2 are the bands
around 37 and 63 kDa, respectively, while the bands around 82
kDa are likely to represent KAHRP. The faint reactivity of the
antibodies to D10 in dot blot analyses may be interpreted as
HRP3 reactivity.
To understand the basis of the differences in reactivities to
the eight isolates, we mapped linear epitopes using synthetic
peptides. We demonstrated that MABs 3A4 and 1E1 recog-
nized the closely related epitopes AHHAHHA and AHHA
HHV, while 2G12-1C12 recognized distinct and longer
epitopes. Attempts to the map the epitope of MAB 4A5 using
peptides resulted in no significant reactivity above background
readings. MAB 4A5 recognized parasite proteins under non-
reduced (dot blot) and reduced (Western blot) conditions but
failed to recognize any 15-mer peptides used in the epitope
scan. Together, these observations suggest that the epitope for
this MAB is linear or partially linear but that it requires more
than 15 amino acids for significant binding.
It would be expected that an antigen with more epitopes
would result in increased detection sensitivity compared to an
antigen with fewer epitopes. Therefore, in principle, the reac-
tivity of each of the three MABs to a given isolate should
correlate with the number of epitopes present in HRP2. We
observed a weak correlation between the reactivity of 3A4 on
dot blot with the number of epitopes and no correlation for
1E1. A possible explanation for our observation of only a weak
association is that the epitopes that we identified are the linear
components of the epitope and that the optimal epitope may
be conformational.
Interestingly, when we analyzed the number of 3A4 and
1E1-A9 epitopes in 71 isolates originating from 19 countries
(1), we observed that the parasites segregated into two groups
with different copy numbers of epitopes for each MAB. Of
note, the geographic origin of the groups differed somewhat
for the two MABs. Most notable is the discordance in South
America, which had the highest frequency of AHHAHHV but
had a lower number of AHHAHHA repeats. This result indi-
cates that the combination of the two MABs may offer the
potential to overcome the difference in sensitivities observed
with HRP-based RDTs recognizing different epitopes.
The identities and specificities of the HRP2-specific MABs
present in commercially available rapid diagnostic tests for
malaria are not known to us. It is clear from this work that
MABs specific for linear epitopes present in P. falciparum
histidine-rich proteins recognize native parasite proteins. Fur-
thermore, with a knowledge of the abundance of specific re-
peats and their geographic spread, it should be possible to
optimize their sensitivities so that they work with acceptable
sensitivity against a broad range of parasites from geographi-
cally distant regions. As noted above, if a universally abundant
epitope cannot be readily identified, a combination of MABs
may overcome the constraints imposed by the diversity of
HRP2 repeats from different regions.
In summary, our findings provide further insight into the
observed variability in sensitivities reported for the various
HRP2-specific RDTs. The genetic diversity of PfHRP2 and its
relationship with the ability of the MABs to bind present a
serious challenge to the future testing and development of
RDTs that target HRP2 for the diagnosis of P. falciparum
infection.
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